|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-12-6
|
|
pubmed:abstractText |
Classification of autoimmune hepatitis (AIH) into different subgroups according to autoantibody status has been proposed: type I (ANA/SMA), type II (LKM-1) and type III (anti-SLA). However, whether type III AIH forms a clinically distinct disease entity remains controversial. The aim of this study was to evaluate the subclassification of AIH into ANA/SMA and anti-SLA positive patients with regard to clinical, biochemical and histologic differences.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
635-40
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10551386-Adult,
pubmed-meshheading:10551386-Antibodies, Antinuclear,
pubmed-meshheading:10551386-Autoantibodies,
pubmed-meshheading:10551386-Autoantigens,
pubmed-meshheading:10551386-Autoimmune Diseases,
pubmed-meshheading:10551386-Female,
pubmed-meshheading:10551386-Hepatitis,
pubmed-meshheading:10551386-Humans,
pubmed-meshheading:10551386-Immunosuppression,
pubmed-meshheading:10551386-Male,
pubmed-meshheading:10551386-Middle Aged,
pubmed-meshheading:10551386-Muscle, Smooth,
pubmed-meshheading:10551386-Prognosis
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.
|
|
pubmed:affiliation |
I. Department of Medicine, Johannes Gutenberg-University, Mainz, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
